Contrast-Enhanced Time-Resolved MRA for Follow-Up of Intracranial Aneurysms Treated with the Pipeline Embolization Device

References

1. 1.↵
   2. Molyneux AJ,
   3. Kerr RSC,
   4. Birks J, et al

   . Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009;8:427–33

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Fiorella D,
   3. Kelly ME,
   4. Turner R, et al

   . Endovascular treatment of cerebral aneurysms: current devices, emerging therapies and future technology for the management of cerebral aneurysms. Endovasc Today 2008;7:53–65
3. 3.↵
   2. Kallmes DF,
   3. Ding YH,
   4. Dai D, et al

   . A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol 2009;30:1153–58

   Abstract/FREE Full Text
4. 4.↵
   2. Becske T,
   3. Kallmes DF,
   4. Saatci I, et al

   . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Delgado Almandoz JE,
   3. Crandall BM,
   4. Fease JL, et al

   . Successful endovascular treatment of three fusiform cerebral aneurysms with the Pipeline embolization device in a patient with dilating HIV vasculopathy. J Neurointerv Surg 2014;6:e12

   Abstract/FREE Full Text
6. 6.↵
   2. Kaufmann TJ,
   3. Huston J 3rd.,
   4. Mandrekar JN, et al

   . Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007;243:812–19

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Schaafsma JD,
   3. Velthuis BK,
   4. Majoie CB, et al

   . Intracranial aneurysms treated with coil placement: test characteristics of follow-up MR angiography—multicenter study. Radiology 2010;256:209–18

   CrossRefPubMed
8. 8.↵
   2. Blackham KA,
   3. Passalacqua MA,
   4. Sandhu GS, et al

   . Applications of time-resolved MR angiography. AJR Am J Roentgenol 2011;196:W613–20

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Cashen TA,
   3. Carr JC,
   4. Shin W, et al

   . Intracranial time-resolved contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol 2006;27:822–29

   Abstract/FREE Full Text
10. 10.↵
    2. Farb RI,
    3. Agid R,
    4. Willinsky RA, et al

    . Cranial dural arteriovenous fistula: diagnosis and classification with time-resolved MR angiography at 3T. AJNR Am J Neuroradiol 2009;30:1546–51

    Abstract/FREE Full Text
11. 11.↵
    2. Choi JW,
    3. Roh HG,
    4. Moon W-J, et al

    . Time-resolved 3D contrast-enhanced MRA on 3.0T: a non-invasive follow-up technique after stent-assisted coil embolization of the intracranial aneurysm. Korean J Radiol 2011;12:662–70

    CrossRefPubMed
12. 12.↵
    2. Kwee TC,
    3. Kwee RM

    . MR angiography in the follow-up of intracranial aneurysms treated with Guglielmi detachable coils: systematic review and meta-analysis. Neuroradiology 2007;49:703–13

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Wall A,
    3. Kugel H,
    4. Bachman R, et al

    . 3.0 T vs. 1.5 T MR angiography: in vitro comparison of intravascular stent artifacts. J Magn Reson Imaging 2005;22:772–79

    CrossRefPubMed
14. 14.↵
    2. Wang Y,
    3. Truong TN,
    4. Yen C, et al

    . Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents. Magn Reson Med 2003;49:972–76

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Fiorella D,
    3. Albuquerque FC,
    4. Deshmukh VR, et al

    . Usefulness of the Neuroform stent for the treatment of cerebral aneurysms: results at initial (3–6-mo) follow-up. Neurosurgery 2005;56:1191–201, discussion 1201–02

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Siddiqui MA,
    3. Bhattacharya J,
    4. Lindsay KW, et al

    . Horizontal stent-assisted coil embolisation of wide-necked intracranial aneurysms with the Enterprise stent: a case series with early angiographic follow-up. Neuroradiology 2009;51:411–18

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Jabbour P,
    3. Chalouhi N,
    4. Tjoumakaris S, et al

    . The Pipeline embolization device: learning curve and predictors of complications and aneurysm obliteration. Neurosurgery 2013;73:113–20, discussion 120

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Majoie CB,
    3. Sprengers ME,
    4. van Rooij WJ, et al

    . MR angiography at 3T versus digital subtraction angiography in the follow-up of intracranial aneurysms treated with detachable coils. AJNR Am J Neuroradiol 2005;26:1349–56

    Abstract/FREE Full Text
19. 19.↵
    2. Wallace RC,
    3. Karis JP,
    4. Partovi S, et al

    . Noninvasive imaging of treated cerebral aneurysms. Part I. MR angiographic follow-up of coiled aneurysms. AJNR Am J Neuroradiol 2007;28:1001–08

    Abstract/FREE Full Text
20. 20.↵
    2. Byrne J,
    3. Szikora I

    . Flow diverters in the management of intracranial aneurysms: a review. EJMINT 2012:1225000057. http://www.ejmint.org/original-article/1225000057. Accessed March 19, 2014.
21. 21.↵
    2. Kaufmann TJ,
    3. Kallmes DF

    . Diagnostic cerebral angiography: archaic and complication-prone or here to stay for another 80 years? AJR Am J Roentgenol 2008;190:1435–37

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Blum MB,
    3. Schmook M,
    4. Schernthaner R, et al

    . Quantification and detectability of in-stent stenosis with CT angiography and MR angiography in arterial stents in vitro. AJR Am J Roentgenol 2007;189:1238–42

    CrossRefPubMed
23. 23.↵
    2. Lettau M,
    3. Sauer A,
    4. Heiland S, et al

    . Carotid artery stents: in vitro comparison of different stent designs and sizes using CT angiography and contrast-enhanced MR angiography at 1.5T and 3T. AJNR Am J Neuroradiol 2009;30:1993–97

    Abstract/FREE Full Text